Tom Völler

1.1k total citations
9 papers, 331 citations indexed

About

Tom Völler is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Immunology. According to data from OpenAlex, Tom Völler has authored 9 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Radiology, Nuclear Medicine and Imaging, 4 papers in Molecular Biology and 3 papers in Immunology. Recurrent topics in Tom Völler's work include Radiopharmaceutical Chemistry and Applications (4 papers), S100 Proteins and Annexins (3 papers) and Medical Imaging Techniques and Applications (2 papers). Tom Völler is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (4 papers), S100 Proteins and Annexins (3 papers) and Medical Imaging Techniques and Applications (2 papers). Tom Völler collaborates with scholars based in United States, Germany and United Kingdom. Tom Völler's co-authors include Kit Brogan, Sven Hermann, Thomas Vogl, Michael Schäfers, Johannes Roth, Andreas Faust, Michel Eisenblätter, Christiane Geyer, Peter van Lent and Stefanie Zenker and has published in prestigious journals such as Nature Communications, Chemical Communications and Journal of Nuclear Medicine.

In The Last Decade

Tom Völler

8 papers receiving 325 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tom Völler United States 7 108 92 74 73 47 9 331
Joannes A. A. Reijers Netherlands 9 94 0.9× 100 1.1× 31 0.4× 48 0.7× 80 1.7× 16 315
P. M. Kern Germany 8 70 0.6× 108 1.2× 12 0.2× 98 1.3× 30 0.6× 10 275
Susan C. Lee United States 9 94 0.9× 42 0.5× 32 0.4× 116 1.6× 181 3.9× 25 390
Adam J. Saenz United States 10 89 0.8× 30 0.3× 20 0.3× 47 0.6× 77 1.6× 15 348
Robin Z. Cheng United States 7 98 0.9× 356 3.9× 16 0.2× 22 0.3× 57 1.2× 7 509
Jutta Gamper Austria 8 74 0.7× 68 0.7× 8 0.1× 59 0.8× 51 1.1× 13 318
Olga Růžičková Czechia 11 115 1.1× 98 1.1× 6 0.1× 67 0.9× 14 0.3× 23 307
Yuka Nishibata Japan 10 102 0.9× 184 2.0× 19 0.3× 9 0.1× 22 0.5× 27 329
Anya Lissina United Kingdom 5 64 0.6× 150 1.6× 112 1.5× 44 0.6× 22 0.5× 7 368

Countries citing papers authored by Tom Völler

Since Specialization
Citations

This map shows the geographic impact of Tom Völler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Völler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Völler more than expected).

Fields of papers citing papers by Tom Völler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Völler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Völler. The network helps show where Tom Völler may publish in the future.

Co-authorship network of co-authors of Tom Völler

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Völler. A scholar is included among the top collaborators of Tom Völler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Völler. Tom Völler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Laforest, Richard, Anchal Ghai, Tyler J. Fraum, et al.. (2024). #27. First-in-human evaluation of safety and dosimetry of 64Cu-LLP2A for PET imaging. Journal of bone oncology. 45. 100565–100565.
2.
Laforest, Richard, Anchal Ghai, Tyler J. Fraum, et al.. (2022). First-in-Humans Evaluation of Safety and Dosimetry of64Cu-LLP2A for PET Imaging. Journal of Nuclear Medicine. 64(2). 320–328. 16 indexed citations
3.
Völler, Tom, Andreas Faust, Johannes Roth, et al.. (2017). A Non-Peptidic S100A9 Specific Ligand for Optical Imaging of Phagocyte Activity In Vivo. Molecular Imaging and Biology. 20(3). 407–416. 4 indexed citations
4.
Laforest, Richard, Andrew Elvington, Gwendalyn J. Randolph, et al.. (2016). PET/MRI of Hypoxic Atherosclerosis Using 64Cu-ATSM in a Rabbit Model. Journal of Nuclear Medicine. 57(12). 2006–2011. 37 indexed citations
5.
Faust, Andreas, Tom Völler, F.W. Busch, et al.. (2015). Development and evaluation of a non-peptidic ligand for the molecular imaging of inflammatory processes using S100A9 (MRP14) as a novel target. Chemical Communications. 51(86). 15637–15640. 17 indexed citations
6.
Mastren, Tara, et al.. (2015). Cyclotron Production of High–Specific Activity 55Co and In Vivo Evaluation of the Stability of 55Co Metal-Chelate-Peptide Complexes. Molecular Imaging. 14(10). 526–33. 25 indexed citations
7.
Brogan, Kit, et al.. (2014). Third-generation minimally invasive correction of hallux valgus: technique and early outcomes. International Orthopaedics. 38(10). 2115–2121. 77 indexed citations
8.
Mastren, Tara, et al.. (2014). Specific activity measurement of 64Cu: A comparison of methods. Applied Radiation and Isotopes. 90. 117–121. 12 indexed citations
9.
Vogl, Thomas, Michel Eisenblätter, Tom Völler, et al.. (2014). Alarmin S100A8/S100A9 as a biomarker for molecular imaging of local inflammatory activity. Nature Communications. 5(1). 4593–4593. 143 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026